Stomach Cancer Trial, Recruiting NCT04312633 Sponsor: CDx Diagnostics Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT04312633
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to read, understand, and sign the study's consent form
  • You are 18 years of age or older
  • You have heartburn or acid reflux and are having a scope procedure (camera down the throat) to check for a condition called Barrett's esophagus, and you will have two specific types of tissue samples taken during that procedure
  • You have already been diagnosed with Barrett's esophagus (with or without pre-cancerous changes) and are having a routine check-up scope with two specific types of tissue samples taken
  • You have previously had a treatment (such as radiofrequency ablation or cryoablation) to remove Barrett's esophagus and are now having a follow-up scope after being confirmed clear, with two specific types of tissue samples taken
  • You must be having both types of tissue sampling (forceps biopsies and a brush-based method called WATS3D) during your scope procedure

Who may not be able to join:

  • You are pregnant at the time of the scope procedure
  • You have an ongoing drug or alcohol dependency that may make it difficult to understand instructions or follow the study plan
  • You have a serious health condition that would likely prevent you from completing a 5-year study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Matthew McKinley, M.D., NYU Langone Health

Phone: 845-777-7000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CDx Diagnostics
Registry
ClinicalTrials.gov
Start date
1 April 2020
Est. completion
1 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary Outcome Measure:

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov